Login / Signup

Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study).

Yongin ChoHyungjin RheeYoung-Eun KimMinyoung LeeByung-Wan LeeEun Seok KangBong-Soo ChaJin-Young ChoiEun Young Lee
Published in: BMC medicine (2022)
The trial was registered at ClinicalTrials.gov (registration number: NCT03434613 ).
Keyphrases
  • combination therapy
  • randomized controlled trial
  • study protocol
  • cardiovascular disease
  • clinical trial
  • coronary artery disease
  • phase iii
  • type diabetes
  • liver fibrosis